Dr. Conor William McLaughlin, MD

Dr. McLaughlin practices at Capital Nephrology Surgery Center in Sacramento, California.

Dr. McLaughlin's NPI, 1962846949, was assigned on April 22, 2013. Dr. McLaughlin graduated from Medical University of South Carolina (MUSC) in 2013. Dr. McLaughlin holds California license A134478.

Dr. McLaughlin's primary practice is Capital Nephrology Surgery Center, at 1111 Exposition Blvd, Sacramento, CA 95815. The practice phone is (916) 564-6232.

Dr. McLaughlin's primary practice is Capital Nephrology Surgery Center in Sacramento, California. Dr. McLaughlin is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is Sacramento Ear, Nose & Throat. Dmand AI also links Dr. McLaughlin to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McLaughlin practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. McLaughlin's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. McLaughlin is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. McLaughlin is licensed in California.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. McLaughlin treats.

CMS data shows 1,012 Medicare services from Dr. McLaughlin across 20 procedure codes in 2024, for 334 Medicare patients. Medicare paid $67,951 for them. Every service was in an office.

CMS counts 334 Medicare patients who saw Dr. McLaughlin in 2024. The largest group is 65 to 74, with 154 patients. 73% of them have high cholesterol, and 72% have high blood pressure. 31% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McLaughlin's median patient age at 46, with 51% women.

In 2024, Dr. McLaughlin wrote 469 Medicare Part D claims for 184 patients. 97% of them were for generic drugs. CMS names the drug for 353 of them, across 13 drugs with 11 or more claims each, at $7,421 in total drug cost. In 2023, CMS named 311 claims across 13 drugs.

Dr. McLaughlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McLaughlin as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. McLaughlin, published from 2014 to 2018. 2017 was the busiest year, with 2. Dr. McLaughlin has published most often in Laryngoscope. Dr. McLaughlin's most frequent co-authors are Dylan Kar-Shuen Chan, MD, PhD, Lawrence R. Lustig, MD and Elliott H. Sherr, MD.

CMS Open Payments shows 29 general payments to Dr. McLaughlin from 10 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 62% of the total. Stryker Corporation paid the most, $1,366.

Dmand AI lists 1 award for Dr. McLaughlin.

Dr. McLaughlin graduated from Medical University of South Carolina (MUSC) in 2013. Dr. McLaughlin is a member of NHS.

Dr. McLaughlin is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.